Postsynaptic 5-HT1A receptors mediate an increase in locomotor activity in the monoamine-depleted rat

Psychopharmacology

Volumn 163, Issue 1, 2002, Pages 85-94

  Mignon, Laurence ^a,b   Wolf, William A ^a,b  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b HINES VA HOSPITAL   (United States)

Author keywords

5 HT1A agonist; 8 OHDPAT; Basal ganglia; Locomotor activity; Parkinson's disease; Rat; Reserpine

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; AUTORECEPTOR; BENSERAZIDE; BUSPIRONE; DOPA; DOPAMINE; FENCLONINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; RESERPINE; SEROTONIN; SEROTONIN 1 AGONIST; SEROTONIN 1 ANTAGONIST; SEROTONIN 1A RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; DRUG EFFECT; LOCOMOTION; MALE; MODULATION; MOTOR NERVE CONDUCTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SEROTONIN RELEASE;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ADRENERGIC UPTAKE INHIBITORS; ANIMALS; BIOGENIC MONOAMINES; BRAIN CHEMISTRY; BUSPIRONE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDROXYINDOLEACETIC ACID; MALE; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PRESYNAPTIC; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; RESERPINE; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SYNAPSES;

EID: 0036366548     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-002-1121-3     Document Type: Article

References (52)

1. An in vivo dialysis and behavioural study of the release of 5-HT by p-chloroamphetamine in reserpine-treated rats
2. 1A receptors in rats
3. 1A receptor agonists on patterns of rat motor activity in relation to effects on forebrain monoamine synthesis
4. Prevention by (±)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol
5. 5-Hydroxytryptamine2 and 5-hydroxytryptamine1A receptors mediate opposing responses on membrane excitability in rat association cortex
6. Excitatory amino acids as neurotransmitters of corticostriatal projections: Immunocytochemical evidence in the rat
7. 2 receptors via the indirect striatal output pathway?
8. Dopaminergic effects of buspirone, a novel anxiolytic agent
9. Intrinsic activity of enantiomers of 8-hydroxy-2-(di-n-propylamino)tetralin and its analogues at 5-hydroxytryptamine1A receptors that are negatively coupled to adenylate cyclase
10. Serotonin depletion produces long lasting increase in striatal glutamatergic transmission
11. 1A antagonist
12. Behavioral effects of serotonin agonists and antagonists in the rat and marmoset
13. Effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on locomotor activity and rearing of mice and rats
14. Dual effects of L-3,4-dihydroxyphenylalanine on aromatic L-amino acid decarboxylase, dopamine release and motor stimulation in the reserpine-treated rat: Evidence that behaviour is dopamine independent
15. 5-Hydroxytryptamine1A but not 5-hydroxytryptamine2 receptors are enriched on neocortical pyramidal neurones destroyed by intrastriatal volkensin
16. Behavioral models of serotonin receptor activation
17. Glutamate-dopamine interactions in the basal ganglia: Relationship to Parkinson's disease
18. Depletion and repletion of cortical tissue and dialysate 5-HT after reserpine
19. The effect of serotonergic agents on haloperidol-induced catalepsy
20. Effects of local application of 5-HT and 8-OHDPAT into the dorsal and median raphe nuclei on motor activity in the rat
21. Effects of 8-OHDPAT on motor activity in the rat
22. 1A receptor agonist, 8-OHDPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo
23. 8-Hydroxy-2-(di-n-propylamino)tetralin, 8-OHDPAT a potent and selective simplified ergot congener with central 5-HT-receptor stimulating activity
24. 8-Hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis
25. 2 receptor antagonists to inhibit methylphenydate-induced behaviors in rats
26. NMDA antagonists potentiate antiparkinsonian actions of L-DOPA in monoamine-depleted rats
27. 5-Hydroxytryptamine release in vivo from a cytoplasmic pool: Studies on the 5-HT behavioural syndrome in reserpinized rats
28. 2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats
29. Potentiation and inhibition of some central actions of L(-)-DOPA by decarboxylase inhibitors
30. 2 receptors
31. Activation of corticostriatal pathway leads to similar morphological changes observed following haloperidol treatment
32. 1A agonists on locomotor and investigatory behaviors in rats differ from those of hallucinogens
33. Serotonergic involvement in haloperidol-induced catalepsy
34. Excitation of noradrenergic cell firing by 5-hydroxytryptamine1A agonists correlates with dopamine antagonist properties
35. 1A receptor in the rat brain: Correlation with receptor binding
36. 1-like receptors on glutamatergic terminals inhibits N-methyl-D-aspartate-induced cyclic GMP production in rat cerebellar slices
37. Long lasting supersensitivity to 5-HT mediated behavior following monoamine depletion in rat brain
38. The discriminative stimulus properties of buspirone involve dopamine-2 receptor antagonist activity
39. Memantine, amantadine and L-deprenyl potentiate the action of L-dopa in monoamine-depleted rats
40. 1/2 balance in the basal ganglia and its relevance to Parkinson's disease
41. Stimulation of basal and L-DOPA-induced motor activity by glutamate antagonists in animal models of Parkinson's disease
42. Actions of 5-hydroxytryptamine on neurons of the rat cingulate cortex
43. The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat
44. Serotonergic mechanisms in neuroleptic-induced catalepsy in the rat
45. 1A autoreceptors by local application of 8-OH-DPAT reverses raclopride-induced catalepsy in the rat
46. Effects of local application of 5-hydroxytryptamine into the dorsal or median raphe nuclei on haloperidol-induced catalepsy in the rat
47. Methyldopa metabolism in central serotonergic nerve terminals: Effects on serotonin levels, synthesis and release
48. Does brain 5-HIAA indicate serotonin release or monoamine oxidase activity?
49. 2 receptor subtype mRNAs in rat brain
50. Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations
51. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin